Staphylococcus aureus binds factor H to moderate complement host defense
金黄色葡萄球菌结合 H 因子以调节补体宿主防御
基本信息
- 批准号:7642971
- 负责人:
- 金额:$ 21.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-05 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAttenuatedBacteriaBindingBiological AssayBiological ModelsCell WallCessation of lifeChemotactic FactorsComplementComplement 3 ConvertaseComplement 3bComplement 5aComplement ActivationComplement Factor HCoupledDepositionDevelopmentDiseaseFeedbackFibrinogenFractionationGenerationsGoalsHealthHeartHost DefenseHumanImmuneImmunologyInfectionInflammation MediatorsInternationalInvestigationJointsMass Spectrum AnalysisMeasuresMediatingMethodologyOsteomyelitisPathogenesisPathway interactionsPneumoniaPostoperative PeriodPreparationPreventionPrincipal InvestigatorProtein BindingProteinsProteomicsPublishingResearchResearch PersonnelRoleSerumSerum ProteinsStaphylococcus aureusStreptococcus pneumoniaeStreptococcus pyogenesSurfaceTechniquesTestingTherapeuticUnited StatesVirulenceWestern BlottingWorkalternative pathway complement C3 convertasedisabilityfactor Agenetic regulatory proteinimplantable devicemethicillin resistant Staphylococcus aureusnovelpathogenpreventprogramsprotein purificationpublic health relevanceskin abscesstandem mass spectrometry
项目摘要
DESCRIPTION (provided by applicant): Staphylococcus aureus is a major health threat in the United States causing skin abscesses, bone infections, joint infections, pneumonias, heart infections, post-operative infections, and infections of implanted devices. Of international concern is the rapidly increasing number of infections caused by methicillin-resistant S. aureus (MRSA). The long-term objective of this proposal is to elucidate S. aureus mechanisms that facilitate evasion of humoral host defense functions as a prerequisite to the development of novel therapies to prevent or attenuate disease. The experimental focus of this proposal is to identify S. aureus cell wall components that bind the host complement regulatory protein factor H and to elucidate the immunomodulatory actions of factor H on the S. aureus surface. Factor H is a serum protein that controls complement activation by destabilizing critical convertases along the complement cascade. The proposed work will build upon our previously published findings that S. aureus binds factor H as well as our new preliminary findings that at least two cell wall components of S. aureus bind purified factor H on overlay Western blot assay. We shall take advantage of the investigator's humoral immune expertise and the proteomic expertise of the George L. Wright Jr. Center for Biomedical Proteomics at EVMS to achieve two specific aims: 1) elucidate the role of factor H binding to S. aureus on complement-mediated host defenses, 2) identify S. aureus cell wall protein(s) that bind factor H. In aim 1 we will use standard microbiologic and complement techniques to measure the effect of factor H in the destabilization of the alternative pathway C3-convertase and the terminal complement cascade C5-convertases on the S. aureus surface. In aim 2 we will use standard protein purification techniques coupled with tandem mass spectrometry to identify S. aurues cell wall components that bind factor H. PUBLIC HEALTH RELEVANCE: The proposed project will characterize interactions between Staphylococcus aureus cell wall and the host immuno-regulatory protein factor H. Understanding how this bacteria manipulates factor H will help identify new targets for prevention and treatment of Staphylococcus aureus infections.
描述(由申请人提供):金黄色葡萄球菌是美国的主要健康威胁,可导致皮肤脓肿、骨感染、关节感染、肺炎、心脏感染、术后感染和植入设备感染。国际社会关注的是耐甲氧西林金黄色葡萄球菌 (MRSA) 引起的感染数量迅速增加。该提案的长期目标是阐明金黄色葡萄球菌促进逃避体液宿主防御功能的机制,这是开发预防或减轻疾病的新疗法的先决条件。本提案的实验重点是鉴定与宿主补体调节蛋白 H 因子结合的金黄色葡萄球菌细胞壁成分,并阐明 H 因子对金黄色葡萄球菌表面的免疫调节作用。 H 因子是一种血清蛋白,通过破坏补体级联中关键转化酶的稳定性来控制补体激活。拟议的工作将建立在我们之前发表的金黄色葡萄球菌结合 H 因子的发现以及我们新的初步发现(在重叠蛋白质印迹测定中金黄色葡萄球菌的至少两种细胞壁成分结合纯化的 H 因子)的基础上。我们将利用研究者的体液免疫专业知识和 EVMS 的 George L. Wright Jr. 生物医学蛋白质组学中心的蛋白质组学专业知识来实现两个具体目标:1) 阐明 H 因子与金黄色葡萄球菌结合对补体介导的宿主防御的作用,2) 鉴定结合 H 因子的金黄色葡萄球菌细胞壁蛋白。在目标 1 中,我们将使用标准微生物学和补体 测量因子 H 在金黄色葡萄球菌表面旁路途径 C3 转化酶和末端补体级联 C5 转化酶不稳定中的影响的技术。在目标 2 中,我们将使用标准蛋白质纯化技术结合串联质谱来鉴定结合 H 因子的金黄色葡萄球菌细胞壁成分。 公共健康相关性:拟议项目将描述金黄色葡萄球菌细胞壁和宿主免疫调节蛋白 H 因子之间的相互作用。了解这种细菌如何操纵 H 因子将有助于确定预防和治疗葡萄球菌的新靶点 金黄色葡萄球菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENJI Mason CUNNION其他文献
KENJI Mason CUNNION的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENJI Mason CUNNION', 18)}}的其他基金
Peptide inhibition of complement-mediated hemolysis after xenotransfusion.
异种输血后补体介导的溶血的肽抑制。
- 批准号:
9129167 - 财政年份:2016
- 资助金额:
$ 21.53万 - 项目类别:
Staphylococcus aureus binds factor H to moderate complement host defense
金黄色葡萄球菌结合 H 因子以调节补体宿主防御
- 批准号:
7825398 - 财政年份:2009
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
6621594 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
7033007 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
6869638 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
6435230 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
6729197 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
Complement and the Clearance of Staphylococcus aureus
金黄色葡萄球菌的补体和清除
- 批准号:
6653926 - 财政年份:2002
- 资助金额:
$ 21.53万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 21.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 21.53万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 21.53万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 21.53万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 21.53万 - 项目类别:
Idea to Innovation